{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:22:55Z","timestamp":1787768575682,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>It is important to study the clinical profile of pediatric patients with acute lymphoblastic leukemia (ALL) and assess various prognostic factors implicated in response to induction chemotherapy for optimal treatment outcomes in India. The present study was done to evaluate the clinical profile and to find the correlation of day 7 and day 28 marrow blast response with already established prognostic factors in children with ALL in the region of North India using MCP 841 protocol for all patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 60 children up to ages 14 years with ALL were given treatment in the form of induction remission (MCP-841 protocol) I1 cycle (induction 1) therapy for 29 days. Complete hemogram for blast cells and bone marrow examination (bone marrow aspiration and, if required, bone marrow biopsy) was done on days 7 and 28 (completion of I1 cycle) to see early bone marrow response. Early response to induction therapy was compared in patients with and without high-risk factors, and results were analyzed statistically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 60 enrolled children, 56 (93.4%) patients were in complete remission at the end of induction 1 cycle. Various risk factors were found to be of prognostic significance in first remission and early response to induction therapy were initial total leukocyte count (TLC) at presentation, immunophenotype of ALL; while other factors including age and sex was not found to be significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Prevalence and significance of various prognostic factors implicated in pediatric ALL tend to be different in various populations. A better understanding of such factors in these populations will help in the tailoring of risk-adapted treatment protocols to local needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijc.ijc_149_20","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:01:58Z","timestamp":1705996918000},"page":"521-527","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India"],"prefix":"10.4103","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6090-8569","authenticated-orcid":false,"given":"Manita","family":"Garg","sequence":"first","affiliation":[{"name":"Department of Peadiatrics, PGIMS, Rohtak, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3193-6990","authenticated-orcid":false,"given":"Pankaj","family":"Abrol","sequence":"additional","affiliation":[{"name":"Department of Peadiatrics, PGIMS, Rohtak, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2414-5680","authenticated-orcid":false,"given":"Nishu","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Peadiatrics, PGIMS, Rohtak, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8937-567X","authenticated-orcid":false,"given":"Shafira","family":"Bharti","sequence":"additional","affiliation":[{"name":"Department of Pathology, Govt. Medical College, Sector 32, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-2803","authenticated-orcid":false,"given":"Anuradha","family":"Nadda","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, PGIMS, Rohtak, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/2278-330X.187591","article-title":"Acute leukemia in children: A review of the current Indian data","volume":"5","author":"Arora","year":"2016","journal-title":"South Asian J Cancer"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.ejca.2004.11.004","article-title":"Treatment of acute lymphoblastic leukemia in countries with limited resources;lessons from use of a single protocol in India over a twenty -year period","volume":"41","author":"Magrath","year":"2005","journal-title":"Eur J Cancer"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4103\/0377-4929.72044","article-title":"Retrospective review of pediatric patients with acute lymphoblastic leukemia: A single center experience","volume":"53","author":"Khalid","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1008366814109","article-title":"Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen","volume":"10","author":"Advani","year":"1999","journal-title":"Ann Oncol"},{"key":"R8-20240828","first-page":"3","article-title":"Childhood acute lymphoblastic leukemia: Indian experience","volume":"20","author":"Bhutani","year":"2004","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1200\/JCO.2007.12.2820","article-title":"Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: The FRALLE 93 study","volume":"26","author":"Oudot","year":"2008","journal-title":"J Clin Oncol"},{"key":"R10-20240828","first-page":"381","article-title":"Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report","volume":"64","author":"Miller","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1200\/JCO.1989.7.12.1807","article-title":"Early response to induction therapy as a predictor of disease -free survival and late recurrence of childhood acute lymhoblastic leukemia: A report from Children Cancer Group","volume":"7","author":"Miller","year":"1989","journal-title":"J Clin Oncol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/1735-1995.178754","article-title":"Analysis of outcomes and prognostic factors of acute lymphoblastic leukemia patients treated by MCP841 protocol: A regional cancer center experience","volume":"21","author":"Kapoor","year":"2016","journal-title":"J Res Med Sci"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPH.0b013e3181d7ae0d","article-title":"Pattern of relapse in childhood ALL: Challenges and lessons from a uniform treatment protocol","volume":"32","author":"Arya","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/0019-509X.175838","article-title":"Nutritional status at presentation, comparison of assessment tools, and importance of arm anthropometry in children with cancer in India","volume":"52","author":"Shah","year":"2015","journal-title":"Indian J Cancer"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/0971-5851.125245","article-title":"Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: An experience from Eastern India","volume":"34","author":"Mukhopadhyay","year":"2013","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0019-509X.84932","article-title":"Time trend in frequency of occurrence of major immunophenotypes in paediatric acute lymphoblastic leukemia cases as experienced by Cancer Institute, Chennai, south India during the period 1989-2009","volume":"48","author":"Rajalekshmy","year":"2011","journal-title":"Indian J Cancer"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pbc.21897","article-title":"Survival outcome in childhood ALL: Experience from a tertiary care center in North India","volume":"53","author":"Kulkarni","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12288-011-0096-9","article-title":"BCR-ABL translocation in pediatric acutelymphoblastic leukemia in Southern India","volume":"28","author":"Sugapriya","year":"2012","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R19-20240828","first-page":"1241","article-title":"Clinico-epidemiological features and response in childhood acute lymphoblastic leukemia at regional cancer center of Northeast India","volume":"8","author":"Saikia","year":"2019","journal-title":"South Asian J Cancer"},{"key":"R20-20240828","first-page":"1684","article-title":"Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia","volume":"75","author":"Aric\u00f2","year":"1995","journal-title":"The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Cancer"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","article-title":"Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL","volume":"99","author":"Willemse","year":"2002","journal-title":"Blood"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0971-5851.171552","article-title":"Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol","volume":"36","author":"Radhakrishnan","year":"2015","journal-title":"Indian J Med Paediatr Oncol"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_149_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:15:23Z","timestamp":1787768123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_149_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_149_20","relation":{},"ISSN":["0019-509X","1998-4774"],"issn-type":[{"value":"0019-509X","type":"print"},{"value":"1998-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2020-02-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}